Oral minoxidil for late alopecia in cancer survivors

Purpose Late alopecia, defined as incomplete hair regrowth > 6 months following cytotoxic chemotherapy or > 6 months from initiation of endocrine therapy, negatively impacts quality of life and may affect dose intensity of adjuvant therapy. This study investigates the effect of oral minoxidil...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Breast cancer research and treatment 2024-12, Vol.208 (3), p.491-499
Hauptverfasser:	Kuo, Alyce Mei-Shiuan, Reingold, Rachel E., Ketosugbo, Kwami F., Pan, Alexander, Kraehenbuehl, Lukas, Dusza, Stephen, Gajria, Devika, Lake, Diana E., Bromberg, Jacqueline F., Traina, Tiffany A., Fornier, Monica N., Gucalp, Ayca, D’Alessandro, Brian M., Rotemberg, Veronica, Dauscher, Megan, Shapiro, Jerry, Goldfarb, Shari B., Markova, Alina, Lacouture, Mario E.
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Oral Adult Aged Alopecia Alopecia - chemically induced Antineoplastic Agents - administration & dosage Antineoplastic Agents - adverse effects Baldness Breast Neoplasms - drug therapy Cancer Cancer Survivors Cancer therapies Chemotherapy Cytotoxicity Endocrine therapy Female Hair Hair - drug effects Hair - growth & development Humans Medicine Medicine & Public Health Middle Aged Minoxidil Minoxidil - administration & dosage Minoxidil - adverse effects Oncology Photography Quality of Life Statistical analysis Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!